GL1X · GenesisL1 explorer

Research workbench

Novel cdk-5 inhibitors - crystal structure of inhibitor efq with cdk-2

Analyse Novel cdk-5 inhibitors - crystal structure of inhibitor efq with cdk-2 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3IGG
Type
protein
Length
290 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cell division protein kinase 2
EC
2.7.11.22
UniProt
P24941
Ligands
ACE, EFQ
Pockets
1 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACell division protein kinase 2 (EC 2.7.11.22)protein29035% helix, 16% strandP24941

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A
  • EFQ · N-[1-(cis-3-hydroxycyclobutyl)-1H-imidazol-4-yl]-2-(4-methoxyphenyl)acetamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13230.720.8435EFQ

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 3IGG · Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-2 · the same entry in another collection · chain A against A, TM-score 1.00
  • P24941 · AlphaFold monomer V2.0 prediction for cyclin-dependent kinase 2 (P24941) · a predicted model of the same protein · chain A against A, TM-score 0.94

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.